| Group |  | |
---|---|---|---|
Gene/polymorphism | Isoflavone | Placebo | P |
CYP17a | Â | Â | Â |
   TT | 32 (40%) | 33 (39%) |  |
   TC | 36 (44%) | 40 (47%) | 0.92 |
   CC | 13 (16%) | 12 (14%) |  |
CYP19b | Â | Â | Â |
   GG | 21 (27%) | 28 (32%) |  |
   GT | 40 (51%) | 45 (52%) | 0.49 |
   TT | 18 (23%) | 14 (16%) |  |
ESR1c | Â | Â | Â |
   CC | 17 (22%) | 19 (22%) |  |
   CT | 39 (51%) | 46 (53%) | 0.95 |
   TT | 21 (27%) | 22 (25%) |  |